Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 14, 2026, 4:02 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1681–1704 of 4,271 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: ADM Clear all

Conditions: Weight Gain
Interventions: Fluid intake app, Survey; Other
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 18 Years and older
Enrollment: 28 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2023
U.S. locations: 1
States / cities: Winston-Salem, North Carolina

Conditions: Changes in Brain Network Connectivity
Interventions: Anesthetics, Dissociative; Drug
Lead sponsor: University of Michigan; Other
Eligibility: 18 Years to 65 Years
Enrollment: 16 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008 – 2015
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: Intervention Group, Control Group
Interventions: Adult Wellbeing CheckUp (AWC), General Healthy Aging Information; Behavioral
Lead sponsor: BellAge Inc.; Industry
Eligibility: 60 Years and older
Enrollment: 496 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Sunnyside, New York

Conditions: Low Back Pain
Interventions: Classification-directed treatment, Non-specific treatment; Behavioral
Lead sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); NIH
Eligibility: 18 Years to 60 Years
Enrollment: 101 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2010
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Smokeless Tobacco Cessation
Interventions: All Nations Snuff Out Smokeless, Healthy Living; Behavioral
Lead sponsor: Lehigh University; Other
Eligibility: 18 Years and older
Enrollment: 384 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2028
U.S. locations: 1
States / cities: Bethlehem, Pennsylvania

Conditions: Breast Cancer
Interventions: sunitinib alone, sunitinib plus paclitaxel, doxorubicin and cyclophosphamide; Drug
Lead sponsor: Indiana University; Other
Eligibility: 18 Years and older
Enrollment: 23 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2010
U.S. locations: 1
States / cities: Indianapolis, Indiana

Conditions: Rheumatoid Arthritis (RA
Interventions: Peer Coach, Healthy Horizons; Behavioral
Lead sponsor: Weill Medical College of Cornell University; Other
Eligibility: 18 Years and older
Enrollment: 250 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2030
U.S. locations: 1
States / cities: New York, New York

Conditions: Colorectal Cancer Metastatic
Interventions: Doxorubicin, FOLFOX, Botensilimab, Balstilimab, Bevacizumab, FOLFIRI, FOLFIRINOX, AGEN2373; Combination Product
Lead sponsor: Northwell Health; Other
Eligibility: 18 Years and older
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2028
U.S. locations: 2
States / cities: Lake Success, New York • New Hyde Park, New York

Conditions: Food Insecurity, Depression, Anxiety
Interventions: Not listed
Lead sponsor: Baylor College of Medicine; Other
Eligibility: 18 Years and older
Enrollment: 2,000 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2027
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Gastroparesis
Interventions: EndoFLIP, Antroduodenal Manometry; Diagnostic Test
Lead sponsor: Northwestern University; Other
Eligibility: 18 Years and older
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2024
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Breast Cancer
Interventions: trastuzumab, cyclophosphamide, doxorubicin hydrochloride, paclitaxel, tamoxifen citrate, conventional surgery; Biological · Drug · Procedure
Lead sponsor: NYU Langone Health; Other
Eligibility: 18 Years and older · Female only
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 1999
U.S. locations: 1
States / cities: New York, New York

Conditions: Breast Cancer
Interventions: trastuzumab, cyclophosphamide, doxorubicin hydrochloride, paclitaxel, conventional surgery; Biological · Drug · Procedure
Lead sponsor: UNC Lineberger Comprehensive Cancer Center; Other
Eligibility: 1 Year to 120 Years · Female only
Enrollment: 82 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 1998 – 2013
U.S. locations: 2
States / cities: Chapel Hill, North Carolina • Winston-Salem, North Carolina

Conditions: Histologically-confirmed Malignancies
Interventions: [18F] FLT, PET/CT scans; Radiation · Device
Lead sponsor: Memorial Sloan Kettering Cancer Center; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2020
U.S. locations: 1
States / cities: New York, New York

Conditions: Breast Cancer
Interventions: high performance liquid chromatography, laboratory biomarker analysis, mass spectrometry, medical chart review; Other
Lead sponsor: University of Nebraska; Other
Eligibility: 19 Years and older · Female only
Enrollment: 27 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2012
U.S. locations: 2
States / cities: Rochester, Minnesota • Omaha, Nebraska

Conditions: Alzheimer Disease, Sleep Initiation and Maintenance Disorders
Interventions: Walking Program, Light Exposure Program, Combined Education, Walking and Light Exposure Program, Routine Medical Care with Education; Behavioral
Lead sponsor: University of Washington; Other
Eligibility: 55 Years and older
Enrollment: 132 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2011
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Obstructive Sleep Apnea (OSA)
Interventions: Weekly phone calls, Frequently asked questions, Usual care; Behavioral
Lead sponsor: CAMC Health System; Other
Eligibility: 18 Years and older
Enrollment: 128 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2009
U.S. locations: 1
States / cities: Charleston, West Virginia

Conditions: Sleep, Parenting, Eating Behavior, Obesity
Interventions: Baby Sleep, Baby Care; Behavioral
Lead sponsor: State University of New York at Buffalo; Other
Eligibility: 18 Years and older
Enrollment: 74 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: Buffalo, New York

Conditions: Colorectal Cancer
Interventions: mHealth for Colorectal cancer screening in Homeless Persons, Control SMS Messages; Behavioral · Other
Lead sponsor: George Washington University; Other
Eligibility: 45 Years to 75 Years
Enrollment: 588 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2030
U.S. locations: 1
States / cities: Washington D.C., District of Columbia

Conditions: Ovarian Cancer
Interventions: Telmisartan; Drug
Lead sponsor: Tyler J Curiel; Other
Eligibility: 18 Years and older · Female only
Enrollment: 33 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2029
U.S. locations: 2
States / cities: Lebanon, New Hampshire • Manchester, New Hampshire

Conditions: Hiv, Fatigue, Mobility Limitation
Interventions: HIIT (intervention), CME (active control), Coaching, Control text message; Behavioral
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 50 Years and older
Enrollment: 118 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2025
U.S. locations: 3
States / cities: Aurora, Colorado • Seattle, Washington

Conditions: Overweight, Obesity
Interventions: SNAPSHOT (Student, Nurses and Parents Seeking Healthy Options Together), Mailed monthly newsletters; Behavioral
Lead sponsor: Temple University; Other
Eligibility: 8 Years to 12 Years
Enrollment: 264 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2019
U.S. locations: 3
States / cities: Amherst, Massachusetts • Minneapolis, Minnesota • Philadelphia, Pennsylvania

Conditions: Malignant Female Reproductive System Neoplasm
Interventions: Hydromorphone, Methadone, Questionnaire Administration; Drug · Other
Lead sponsor: Mayo Clinic; Other
Eligibility: Female only
Enrollment: 140 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2029
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Breast Cancer
Interventions: bevacizumab, capecitabine, cyclophosphamide, docetaxel, doxorubicin hydrochloride (Adriamycin), gemcitabine hydrochloride; Biological · Drug
Lead sponsor: NSABP Foundation Inc; Network
Eligibility: 18 Years to 120 Years · Female only
Enrollment: 1,206 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2018
U.S. locations: 432
States / cities: Little Rock, Arkansas • Castro Valley, California • Fremont, California + 287 more

Conditions: Non-Hodgkin's Lymphoma
Interventions: Obinutuzumab, Cyclophosphamide, Doxorubicin, Vincristine, Prednisone, Bendamustine, Rituximab; Drug
Lead sponsor: Hoffmann-La Roche; Industry
Eligibility: 18 Years and older
Enrollment: 1,401 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2021
U.S. locations: 12
States / cities: Springdale, Arkansas • Irvine, California • Post Falls, Idaho + 9 more

Search by objective public record fields.

Development of Fluid Intake App for Management of Fluid Intake During Hemodialysis

Anesthesia and Functional Connectivity: An Analysis of fMRI Changes

Innovative Web-based Service Platform Called Adult Wellbeing CheckUp (AWC) to Assess Older Adults Wellbeing, Obtain Evidence-based Recommendations, and Receive Support to Take Action.

Classification-Directed Treatment of Low Back Pain

Testing ANSOS for Efficacy in Multi-Tribal Urban Communities

Exploratory Study of Sunitinib Malate as a Component of Neoadjuvant Therapy for Breast Cancer

Healthier: Health Coaching for People With Rheumatoid Arthritis to Improve Mental Well-Being

Pilot Study of an Implantable Microdevice for In Situ Evaluation of Drug Response in Patients With Colorectal Liver Metastasis

Neurodevelopmental Outcomes in Children: Strengthening the Caregiver-Child Story

Use of EndoFLIP and Manometry Prior to G-POEM

Trastuzumab and Chemotherapy Followed by Surgery and Combination Chemotherapy in Treating Women With Locally Advanced Breast Cancer

Multimodality Treatment for Women With Stage II, Stage III, or Stage IV Breast Cancer

Serial FLT PET Imaging in Cancer Patients for Monitoring of Response to Therapy

Effect of Tamoxifen or an Aromatase Inhibitor on Estrogen Metabolism in Women Treated for Newly Diagnosed Breast Cancer

Using Behavioral Programs to Treat Sleep Problems in Individuals With Alzheimer's Disease

Weekly Phone Calls Versus Brief Patient Education to Improve CPAP (Continuous Positive Airway Pressure) Compliance

The Baby Care Study

Colorectal Cancer Screening in the Homeless

Telmisartan in Combination With Cytotoxic Regimens in Platinum-Resistant Ovarian Cancer

High-Intensity Exercise to Attenuate Limitations and Train Habits in Older Adults With HIV

School Nurse-directed Secondary Obesity Prevention for Elementary School Children

Methadone Versus Intrathecal Hydromorphone for Postoperative Pain Relief in Gynecologic Cancer Undergoing Surgery

Chemotherapy With or Without Bevacizumab in Treating Women With Stage I, Stage II, or Stage IIIA Breast Cancer That Can Be Removed By Surgery

A Study of Obinutuzumab (RO5072759) Plus Chemotherapy in Comparison With Rituximab Plus Chemotherapy Followed by Obinutuzumab or Rituximab Maintenance in Patients With Untreated Advanced Indolent Non-Hodgkin's Lymphoma (GALLIUM)